Medium Chain Triglycerides improve bioavailability of CBDs

Dr./Prof. Alvin Berger, CEO SciaEssentials and SciaDonics, Co-Founder LifeSense Products, December 2019

Introduction. In this invited review, we are honored to have Dr/Professor Alvin Berger describe the current challenge of poor bioavailability of CBD, and how bioavailability can be improved by various means, including use of medium chain triglycerides (MCTs). Dr. Berger is a published expert on lipids including MCTs, with academic, industrial and commercial experience. He has also published landmark papers on endocannabinoids and phytocannabinoids in prestigious journals with Raphael Mechoulam and Vincenzo Di Marzo, leaders in the cannabinoid field.